190 related articles for article (PubMed ID: 36076294)
1. Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia.
Chen Y; Li K; Zhao H; Hao Z; Yang Y; Gao M; Zhao D
J Transl Med; 2022 Sep; 20(1):412. PubMed ID: 36076294
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of the components compatibility of Scutellariae Radix and Coptidis Rhizoma on mice with hyperlipidemia by regulating the Cyp4a family.
Gao Y; Sun YY; Bai D; Wu XX
J Ethnopharmacol; 2024 Sep; 331():118263. PubMed ID: 38677575
[TBL] [Abstract][Full Text] [Related]
3. [Mechanism of Didang Decoction in prevention of anti-atherosclerosis and hyperlipidemia by HPLC-Q-TOF-MS/MS and network pharmacology based on theory of "nutrients return to heart and fat accumulates in channels"].
Wu XZ; Kang J; Li Y; Pan JX
Zhongguo Zhong Yao Za Zhi; 2023 Mar; 48(5):1352-1369. PubMed ID: 37005819
[TBL] [Abstract][Full Text] [Related]
4. Integrated lipidomics, transcriptomics and network pharmacology analysis to reveal the mechanisms of Danggui Buxue Decoction in the treatment of diabetic nephropathy in type 2 diabetes mellitus.
Sun L; Yang Z; Zhao W; Chen Q; Bai H; Wang S; Yang L; Bi C; Shi Y; Liu Y
J Ethnopharmacol; 2022 Jan; 283():114699. PubMed ID: 34610419
[TBL] [Abstract][Full Text] [Related]
5. Effect of Berberine on Hyperuricemia and Kidney Injury: A Network Pharmacology Analysis and Experimental Validation in a Mouse Model.
Li Q; Huang Z; Liu D; Zheng J; Xie J; Chen J; Zeng H; Su Z; Li Y
Drug Des Devel Ther; 2021; 15():3241-3254. PubMed ID: 34349501
[TBL] [Abstract][Full Text] [Related]
6. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology combined with metabolomics and lipidomics to reveal the hypolipidemic mechanism of
Yan P; Wei Y; Wang M; Tao J; Ouyang H; Du Z; Li S; Jiang H
Food Funct; 2022 Apr; 13(8):4714-4733. PubMed ID: 35383784
[No Abstract] [Full Text] [Related]
8. Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters.
Li XY; Zhao ZX; Huang M; Feng R; He CY; Ma C; Luo SH; Fu J; Wen BY; Ren L; Shou JW; Guo F; Chen Y; Gao X; Wang Y; Jiang JD
J Transl Med; 2015 Aug; 13():278. PubMed ID: 26310319
[TBL] [Abstract][Full Text] [Related]
9. Integrated non-targeted metabolomics and network pharmacology to reveal the mechanisms of berberine in the long-term treatment of PTZ-induced epilepsy.
Zhu H; Wu Z; Yu Y; Chang K; Zhao C; Huang Z; He W; Luo Z; Huang H; Zhang C
Life Sci; 2024 Jan; 336():122347. PubMed ID: 38103728
[TBL] [Abstract][Full Text] [Related]
10. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
[TBL] [Abstract][Full Text] [Related]
11. Ameliorative effects of the Coptis inflorescence extract against lung injury in diabetic mice by regulating AMPK/NEU1 signaling.
Wang L; Wang J; Ren G; Sun S; Nishikawa K; Yu J; Zhang C
Phytomedicine; 2023 Sep; 118():154963. PubMed ID: 37516057
[TBL] [Abstract][Full Text] [Related]
12. Uncovering the mechanism of Astragali Radix against nephrotic syndrome by intergrating lipidomics and network pharmacology.
Li AP; Yang L; Cui T; Zhang LC; Liu YT; Yan Y; Li K; Qin XM
Phytomedicine; 2020 Oct; 77():153274. PubMed ID: 32771537
[TBL] [Abstract][Full Text] [Related]
13. Integrated metabolomics and network pharmacology to reveal the lipid-lowering mechanisms of Qizha Shuangye granules in hyperlipidemic rats.
Zhao L; Wang S; Xu X; Guo W; Yang J; Liu Y; Xie S; Piao G; Xu T; Wang Y; Xu Y
J Sci Food Agric; 2024 Apr; 104(6):3265-3274. PubMed ID: 38087399
[TBL] [Abstract][Full Text] [Related]
14. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
15. Ultra-high performance liquid chromatography-quadrupole/time-of-flight mass spectrometry-based lipidomics reveals key lipid molecules as potential therapeutic targets of Polygonum cuspidatum against hyperlipidemia in a hamster model.
Yang N; Hu W; He J; Wu X; Zou T; Zheng J; Zhao C; Wang M
J Sep Sci; 2023 May; 46(9):e2200844. PubMed ID: 36815210
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
17. Integrated Lipidomics and Network Pharmacology Reveal Mechanism of Memory Impairment Improvement by Yuanzhi San.
Zhao F; Li P; Deng F; Wang J; Cheng Y; Pei K; Wang Y; Wang Y
Chem Biodivers; 2023 Mar; 20(3):e202200920. PubMed ID: 36683009
[TBL] [Abstract][Full Text] [Related]
18. Research and experimental verification of the molecular mechanism of berberine in improving premature ovarian failure based on network pharmacology.
Xue W; Xue F; Jia T; Hao A
Bioengineered; 2022 Apr; 13(4):9885-9900. PubMed ID: 35420511
[TBL] [Abstract][Full Text] [Related]
19. Intestines-erythrocytes-mediated bio-disposition deciphers the hypolipidemic effect of berberine from Rhizoma Coptidis: A neglected insight.
Huang Z; Li M; Qin Z; Ma X; Huang R; Liu Y; Xie J; Zeng H; Zhan R; Su Z
J Ethnopharmacol; 2023 Oct; 314():116600. PubMed ID: 37196811
[TBL] [Abstract][Full Text] [Related]
20. Berberine is a potential alternative for metformin with good regulatory effect on lipids in treating metabolic diseases.
Guo HH; Shen HR; Wang LL; Luo ZG; Zhang JL; Zhang HJ; Gao TL; Han YX; Jiang JD
Biomed Pharmacother; 2023 Jul; 163():114754. PubMed ID: 37094549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
